← Back to all trials
Completed
NCT07603869
Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2026
Conditions: Cardiovascular Risks
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Enrollment: 511
Sponsor: European Society of Cardiology
Location: Cankarjev Dom Ljubljana
Summary
The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens.
In line with this call for public health diagnosis of CV health, the ESC, through the European Association of Preventive Cardiology (EAPC), is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Preventive Cardiology Congress 2026 from 23-24 April 2026 in Ljubljana, Slovenia.
The primary objective of the study is to screen the CV risk among the ESC Annual Congress 2026 attendees with a focus on healthcare professionals (HCP) and to stratify by primary or secondary prevention.
Eligibility Criteria
Inclusion Criteria:
* All attendees including healthcare professionals (doctors, nurses, etc.) attending the EAPC Congress 2026 from 23 to 24 April 2026
* Subjects who declare that they are able to understand and give informed consent in English
Exclusion Criteria:
* Subjects not willing to provide his/her consent to participate in the study.
* Subjects who are not suitable candidates for blood extraction.
Source: ClinicalTrials.gov (NCT07603869). StuddyBuddy aggregates publicly available trial information.